 | • レポートコード：C-GIR20G0722 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「勃起不全治療薬の世界市場2019年」は、グローバルにおける勃起不全治療薬市場を展望するレポートです。勃起不全治療薬のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・勃起不全治療薬の市場概観 ・勃起不全治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・勃起不全治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・勃起不全治療薬の世界市場規模 ・勃起不全治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・勃起不全治療薬のアメリカ市場規模推移 ・勃起不全治療薬のカナダ市場規模推移 ・勃起不全治療薬のメキシコ市場規模推移 ・勃起不全治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・勃起不全治療薬のドイツ市場規模推移 ・勃起不全治療薬のイギリス市場規模推移 ・勃起不全治療薬のロシア市場規模推移 ・勃起不全治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・勃起不全治療薬の日本市場規模推移 ・勃起不全治療薬の中国市場規模推移 ・勃起不全治療薬の韓国市場規模推移 ・勃起不全治療薬のインド市場規模推移 ・勃起不全治療薬の東南アジア市場規模推移 ・勃起不全治療薬の南米市場分析（ブラジル、アルゼンチン等） ・勃起不全治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・勃起不全治療薬の種類別分析/販売量、売上、市場シェア（シルデナフィル、タダラフィル、その他） ・勃起不全治療薬の用途別分析/市場規模（病院薬局、プライベートクリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C）） ・勃起不全治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・勃起不全治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Erectile Dysfunction Drugs is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 6496.4 million US$ in 2024, from 5188.6 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Erectile Dysfunction Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Dong-A ST
Metuchen Pharma
BaiYunShan General Factory
Pfizer
Eli Lilly
Bayer
CSBIO.
Teva Pharma
S.K. Chemicals
Seoul Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sildenafil
Tadalafil
Others
In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.
Market Segment by Applications, can be divided into
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erectile Dysfunction Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction Drugs, with price, sales, revenue and global market share of Erectile Dysfunction Drugs in 2017 and 2018.
Chapter 3, the Erectile Dysfunction Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Erectile Dysfunction Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Erectile Dysfunction Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Erectile Dysfunction Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Sildenafil
1.2.2 Tadalafil
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Private Clinics
1.3.3 Retail Pharmacies
1.3.4 E-Commerce (B2B)
1.3.5 E-Commerce (B2C)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dong-A ST
2.1.1 Business Overview
2.1.2 Erectile Dysfunction Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Metuchen Pharma
2.2.1 Business Overview
2.2.2 Erectile Dysfunction Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 BaiYunShan General Factory
2.3.1 Business Overview
2.3.2 Erectile Dysfunction Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Erectile Dysfunction Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Erectile Dysfunction Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Erectile Dysfunction Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 CSBIO.
2.7.1 Business Overview
2.7.2 Erectile Dysfunction Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharma
2.8.1 Business Overview
2.8.2 Erectile Dysfunction Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 S.K. Chemicals
2.9.1 Business Overview
2.9.2 Erectile Dysfunction Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Seoul Pharma
2.10.1 Business Overview
2.10.2 Erectile Dysfunction Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Erectile Dysfunction Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Erectile Dysfunction Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Erectile Dysfunction Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Erectile Dysfunction Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Erectile Dysfunction Drugs Market Analysis by Regions
4.1 Global Erectile Dysfunction Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
4.5 South America Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
5 North America Erectile Dysfunction Drugs by Country
5.1 North America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Erectile Dysfunction Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Erectile Dysfunction Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
6 Europe Erectile Dysfunction Drugs by Country
6.1 Europe Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Erectile Dysfunction Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Erectile Dysfunction Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
6.3 UK Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
6.4 France Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Erectile Dysfunction Drugs by Country
7.1 Asia-Pacific Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Erectile Dysfunction Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Erectile Dysfunction Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
7.5 India Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
8 South America Erectile Dysfunction Drugs by Country
8.1 South America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Erectile Dysfunction Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Erectile Dysfunction Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Erectile Dysfunction Drugs by Countries
9.1 Middle East and Africa Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
10 Global Erectile Dysfunction Drugs Market Segment by Type
10.1 Global Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2014-2019)
10.2 Sildenafil Sales Growth and Price
10.2.1 Global Sildenafil Sales Growth (2014-2019)
10.2.2 Global Sildenafil Price (2014-2019)
10.3 Tadalafil Sales Growth and Price
10.3.1 Global Tadalafil Sales Growth (2014-2019)
10.3.2 Global Tadalafil Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Erectile Dysfunction Drugs Market Segment by Application
11.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Private Clinics Sales Growth (2014-2019)
11.4 Retail Pharmacies Sales Growth (2014-2019)
11.5 E-Commerce (B2B) Sales Growth (2014-2019)
11.6 E-Commerce (B2C) Sales Growth (2014-2019)
12 Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.1 Global Erectile Dysfunction Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Erectile Dysfunction Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.2.2 Europe Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.2.4 South America Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Erectile Dysfunction Drugs Market Forecast (2019-2024)
12.3 Erectile Dysfunction Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Erectile Dysfunction Drugs Market Share Forecast by Type (2019-2024)
12.4 Erectile Dysfunction Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Erectile Dysfunction Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Erectile Dysfunction Drugs Picture
Table Product Specifications of Erectile Dysfunction Drugs
Figure Global Sales Market Share of Erectile Dysfunction Drugs by Types in 2018
Table Erectile Dysfunction Drugs Types for Major Manufacturers
Figure Sildenafil Picture
Figure Tadalafil Picture
Figure Others Picture
Figure Erectile Dysfunction Drugs Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Private Clinics Picture
Figure Retail Pharmacies Picture
Figure E-Commerce (B2B) Picture
Figure E-Commerce (B2C) Picture
Figure United States Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Dong-A ST Basic Information, Manufacturing Base and Competitors
Table Dong-A ST Erectile Dysfunction Drugs Type and Applications
Table Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table Metuchen Pharma Erectile Dysfunction Drugs Type and Applications
Table Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BaiYunShan General Factory Basic Information, Manufacturing Base and Competitors
Table BaiYunShan General Factory Erectile Dysfunction Drugs Type and Applications
Table BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Erectile Dysfunction Drugs Type and Applications
Table Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Erectile Dysfunction Drugs Type and Applications
Table Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Erectile Dysfunction Drugs Type and Applications
Table Bayer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CSBIO. Basic Information, Manufacturing Base and Competitors
Table CSBIO. Erectile Dysfunction Drugs Type and Applications
Table CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharma Basic Information, Manufacturing Base and Competitors
Table Teva Pharma Erectile Dysfunction Drugs Type and Applications
Table Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table S.K. Chemicals Erectile Dysfunction Drugs Type and Applications
Table S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table Seoul Pharma Erectile Dysfunction Drugs Type and Applications
Table Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Erectile Dysfunction Drugs Sales by Manufacturer (2017-2018)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Manufacturer in 2017
Figure Global Erectile Dysfunction Drugs Sales Market Share by Manufacturer in 2018
Table Global Erectile Dysfunction Drugs Revenue by Manufacturer (2017-2018)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Erectile Dysfunction Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Erectile Dysfunction Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table Global Erectile Dysfunction Drugs Sales by Regions (2014-2019)
Table Global Erectile Dysfunction Drugs Sales Market Share by Regions (2014-2019)
Table Global Erectile Dysfunction Drugs Revenue by Regions (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Regions in 2018
Figure North America Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Europe Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure South America Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure North America Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table North America Erectile Dysfunction Drugs Sales by Countries (2014-2019)
Table North America Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table North America Erectile Dysfunction Drugs Revenue by Countries (2014-2019)
Table North America Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure United States Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Canada Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Europe Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table Europe Erectile Dysfunction Drugs Sales by Countries (2014-2019)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Table Europe Erectile Dysfunction Drugs Revenue by Countries (2014-2019)
Figure Europe Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure Germany Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure UK Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure France Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Russia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Italy Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Erectile Dysfunction Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Erectile Dysfunction Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Erectile Dysfunction Drugs Revenue Market Share by Countries 2018
Figure China Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Japan Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Korea Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure India Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure South America Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table South America Erectile Dysfunction Drugs Sales by Countries (2014-2019)
Table South America Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure South America Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table South America Erectile Dysfunction Drugs Revenue by Countries (2014-2019)
Table South America Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Erectile Dysfunction Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure UAE Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2014-2019)
Table Global Erectile Dysfunction Drugs Sales by Type (2014-2019)
Table Global Erectile Dysfunction Drugs Sales Share by Type (2014-2019)
Table Global Erectile Dysfunction Drugs Revenue by Type (2014-2019)
Table Global Erectile Dysfunction Drugs Revenue Share by Type (2014-2019)
Figure Global Sildenafil Sales Growth (2014-2019)
Figure Global Sildenafil Price (2014-2019)
Figure Global Tadalafil Sales Growth (2014-2019)
Figure Global Tadalafil Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Erectile Dysfunction Drugs Sales by Application (2014-2019)
Table Global Erectile Dysfunction Drugs Sales Share by Application (2014-2019)
Figure Global Hospital Pharmacies Sales Growth (2014-2019)
Figure Global Private Clinics Sales Growth (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global E-Commerce (B2B) Sales Growth (2014-2019)
Figure Global E-Commerce (B2C) Sales Growth (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Erectile Dysfunction Drugs Sales Forecast by Regions (2019-2024)
Table Global Erectile Dysfunction Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Erectile Dysfunction Drugs Market Forecast (2019-2024)
Figure Europe Sales Erectile Dysfunction Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Erectile Dysfunction Drugs Market Forecast (2019-2024)
Figure South America Sales Erectile Dysfunction Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Erectile Dysfunction Drugs Market Forecast (2019-2024)
Table Global Erectile Dysfunction Drugs Sales Forecast by Type (2019-2024)
Table Global Erectile Dysfunction Drugs Market Share Forecast by Type (2019-2024)
Table Global Erectile Dysfunction Drugs Sales Forecast by Application (2019-2024)
Table Global Erectile Dysfunction Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
勃起不全(ED)薬市場：世界及び中国市場分析・予測（～2024年） Erectile Dysfunction(ED) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Erectile Dysfunction(ED) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Erectile D…- 勃起不全治療の世界市場 2019年版：種類別（経口治療、陰茎インプラント、真空収縮装置、衝撃波療法）、用途別（病院、スペシャリストクリニック、その他） Description Scope of the Report: The global Erectile Dysfunction Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, esp…
- 勃起不全治療薬販売市場：世界及び中国市場分析・予測（～2024年） Erectile Dysfunction Drug Sales Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Erectile Dysfunction Drug Sales industry with a focus on the Chinese market. The report provides key statistics on the market status of the Erecti…
- ホスホジエステラーゼタイプ5（PDE5）阻害剤の世界市場 2019年版：種類別（シルデナフィル、タダラフィル、アバナフィル、バルデナフィル）、用途別（病院、小売薬局、オンライン薬局、その他） Description Scope of the Report: The global Phosphodiesterase Type 5 (PDE5) Inhibitor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following…
- 世界の子宮内膜症治療薬市場予測（～2024年） Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condi…